Chargement en cours...
Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer
A total of 16 premenopausal women with metastatic breast cancer (N=13) or locally advanced primary breast cancer (N=3) were treated with a combination of a gonadotropin-releasing hormone agonist goserelin, and a selective aromatase inhibitor anastrozole. All had previously been treated with gosereli...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Nature Publishing Group
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2409605/ https://ncbi.nlm.nih.gov/pubmed/14760369 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601557 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|